Literature DB >> 7988783

Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population.

I Buyse1, L A Sandkuyl, M Zamani Ghabanbasani, X X Gu, R Bouillon, M Bex, L Dooms, M P Emonds, M Duhamel, P Marynen.   

Abstract

Using a highly discriminatory DNA typing technique, based on the polymerase chain reaction and reverse dot blot hybridization, more refined results were obtained on the association of particular HLA class II alleles, haplotypes and genotypes with insulin-dependent diabetes mellitus in the Belgian population. The previously reported predisposing effect for the DRB1*0301 encoded DR3 serologic specificity was confirmed and could be assigned to the DRB3*0200 encoded DR52b serologic specificity. A second high risk haplotype, DRB1*0401-DQB1*0302 encoding the DR4-DQ8 serologic specificity, accounted for increased susceptibility both in the total insulin-dependent diabetic population and among DR4-positive patients. Moreover, we found that these DR4 associated DRB1 and DQB1 alleles act as independent risk factors. A possible role for the DPB1 locus can be rejected since the observed predisposing effect for DPB1*0202 probably occurred due to linkage disequilibrium of this allele with DRB1*0301. Particular extended haplotypes accounted for the decreased relative risk observed for the DR2, DR11 and DR13 serologic specificities. The highest relative risk was observed for those DQA1/DQB1 genotypes, allowing for the formation of 4SS (DQ alpha Arg52+/DQ beta Asp57-) heterodimers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988783     DOI: 10.1007/BF00404338

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1992-04

Review 3.  Genetics of diabetes. Trans-racial gene mapping studies.

Authors:  C H Mijovic; A H Barnett; J A Todd
Journal:  Baillieres Clin Endocrinol Metab       Date:  1991-06

4.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 5.  Human class II major histocompatibility complex genes and proteins.

Authors:  D Kappes; J L Strominger
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

6.  Novel class II HLA-DRB4 and DPB1 alleles found in the Belgian population.

Authors:  I Buyse; M P Emonds; R Bouillon; P Marynen; J J Cassiman
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 7.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.

Authors:  G Thomson; W P Robinson; M K Kuhner; S Joe; M J MacDonald; J L Gottschall; J Barbosa; S S Rich; J Bertrams; M P Baur
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

8.  The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus.

Authors:  K S Rønningen; T Iwe; T S Halstensen; A Spurkland; E Thorsby
Journal:  Hum Immunol       Date:  1989-11       Impact factor: 2.850

9.  The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins.

Authors:  P Olmos; R A'Hern; D A Heaton; B A Millward; D Risley; D A Pyke; R D Leslie
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

10.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more
  5 in total

1.  HLA-A associations with IDDM--a case of numbers?

Authors:  E Bonifacio
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

2.  Linkage and association of the HLA gene complex with IDDM in 81 Danish families: strong linkage between DR beta 1Lys71+ and IDDM.

Authors:  M Zamani; F Pociot; M Spaepen; P Raeymaekers; J Nerup; J J Cassiman
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

3.  IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.

Authors:  M Walter; E Albert; M Conrad; E Keller; M Hummel; K Ferber; B J Barratt; J A Todd; A-G Ziegler; E Bonifacio
Journal:  Diabetologia       Date:  2003-05-16       Impact factor: 10.122

4.  HLA-DQ screening for risk assessment of insulin dependent diabetes in northern Italy.

Authors:  V Lampasona; M Ferrari; E Bonifacio; M R Pastore; P Carrera; A Sergi; S Genovese; M Trucco; J Dorman; E Bosi
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

5.  A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.

Authors:  Christian S Parry; Bernard R Brooks
Journal:  Biol Direct       Date:  2008-10-14       Impact factor: 4.540

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.